Rothschild Investment LLC Tarsus Pharmaceuticals, Inc. Transaction History
Rothschild Investment LLC
- $1.53 Trillion
- Q3 2024
A detailed history of Rothschild Investment LLC transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 40 shares of TARS stock, worth $1,871. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40
Previous 10
300.0%
Holding current value
$1,871
Previous $272,000
383.82%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding TARS
# of Institutions
160Shares Held
41.1MCall Options Held
37.9KPut Options Held
808K-
Rtw Investments, LP New York, NY3.41MShares$160 Million1.55% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$153 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.44MShares$114 Million2.68% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$106 Million7.48% of portfolio
-
Cowen And Company, LLC2.2MShares$103 Million1.53% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.25B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...